Condition
Lung Disease, Interstitial
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
80.0%-7% vs avg
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
80.0%
-6.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
80% success
Data Visualizations
Phase Distribution
1Total
P 3 (1)
Trial Status
Completed4
Terminated1
Trial Success Rate
80.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07686562CompletedPrimary
Artificial Intelligence (AI) Detection of Incidental Interstitial Opacity on Chest Radiography
NCT02990286Phase 3CompletedPrimary
Evaluation of Efficacy and Safety of Rituximab With Mycophenolate Mofetil in Patients With Interstitial Lung Diseases
NCT00815711CompletedPrimary
Idiopathic Pulmonary Fibrosis Registry for Future Studies
NCT01361139Completed
Diagnosis of Cardio-Pulmonary Pathology Using Transthoracic Parametric Doppler (TPD)
NCT01618721Terminated
Detection and Characterization of Pulmonary Disease by Transthoracic Doppler (TTD)
Showing all 5 trials